Bachem Holding AG (BANB.SW)
Bachem Holding AG, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
77.70+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+12.2%
The outlook
Bachem Holding AG currently reads as leaning bullish based on buy — 2.2 avg of 10 analysts, above its 50- & 200-day averages, 84% of the way from its 52-week low to high, avg target +5% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 10 analysts81.40average target+4.8% vs now
Now 77.70
Low 52.00High 110.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.82B
52-wk high
83.25
52-wk low
48.52
50-day avg
72.71
200-day avg
64.69
Trailing P/E
39.2